Investment Column: Wincanton can drive returns for investors

Low & Bonar; Synergy Health


Our view: Buy

Share price: 181p (+14p)

We have never met a company that claims to have anything other than great relationships with its customers.

Wincanton, the haulier, is no different, with chief executive Graeme McFaull saying it is strong client relationships that are key to the group emerging fitter and leaner from the recession. Maybe, but from an investment point of view, we would instead applaud the company for its cost-cutting and efficiency efforts to counter the downturn, which have helped the group to maintain its dividend despite the falling profits that were announced in yesterday's preliminary results.

And the real reason, in our opinion, for the nearly 50 per cent rise in the stock over the last three months is that Wincanton has acted to bring down its debt and reduce its pension deficit. The experts at Arden Partners were so encouraged yesterday that they started advising clients to buy the shares.

We would agree that there is plenty of juice left in the shares, but certainly think Wincanton would be at the riskier end of any portfolio: the company itself expects volumes to continue to fall, until at least the financial year end next March, and while it is right to start renegotiating its debt facilities, which expire next November, a deal is yet to be done with the banks.

The fact that the shares, which trade on a forward price-earnings ratio of nearly eight times, are at an undemanding level would convince us to buy, so long as the company continues to look for more efficiency (maintaining good relationships with clients is an absolute minimum investors should expect). We do still see Wincanton as vulnerable, however, and punters should be prepared to sell on future signs of weakness. Buy.

Low & Bonar

Our view: Hold for now

Share price: 29p (-0.25p)

Nearly a year ago, when we last wrote about Low & Bonar, its chief executive, Paul Forman, said he had no idea why the group's share price was not reflecting its genuinely impressive performance.

In truth, little has changed in the last 12 months and the head-scratching continues. The specialist materials group which supplies fabric and fibres to a variety of industries, including the still buoyant civil engineering sector, issued its half-year trading update yesterday: performance is in line with expectations, the group says, and there is a real kicker from lower raw material costs and tighter cost controls. The shares, argue the experts at Evolution, trade at a discount, and buyers can expect a level of 40p before too long.

All that is very well indeed, but there is no point buying even the most robust company in the world if its shares continue to flounder. We argued that readers should buy last year as the shares looked ludicrously cheap. While the stock suffered, as did most, in the nuclear winter that followed the collapse of Lehman Brothers last September, it is still, for whatever reason, underperforming the market.

True, the wider market may regard the group as being too closely aligned with the still toxic construction sector, even though it is not in practice.

Mr Forman concedes that current shareholders are frustrated by the group's share price performance. We see no reason why those not already on the register should risk the agitation, and although Low & Bonar is a successful and well-run company, we would wait on the stock, until it shows more signs of life.

Synergy Health

Our view: Buy

Share price: 470p (+55.25p)

There are a number of so-called, and often self-proclaimed, experts doing cerebral battle over what shape the economic recovery will be. Notions of W, V, U, and bizarrely enough, hippopotamus-shaped returns to financial health have all had their 15 minutes of fame recently.

Those holding shares in the healthcare services provider Synergy know exactly what shape best represents the fall in their investment in the last few months: L. Last October the group, which frankly should be as secure as Fort Knox, issued a profits warning after being hit with a rise in energy and currency costs. The share price dropped from nearly 700p to about 400p overnight, and has not recovered since.

The problems are behind the group, says its chief executive, Richard Steeves, who argues that only further unexpected economic strife worries him. The company issued in-line annual numbers yesterday, prompting Dr Stevens to argue that the shares are at depressed levels; if Synergy can maintain its performance, the stock's 10 per cent discount to others in the sector will soon be eroded, he says.

The stock was up 13.3 per cent yesterday, showing that it has its supporters. We think there is more to come and would back the shares now. Buy.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
Life and Style
A still from the 1939 film version of Margaret Mitchell's 'Gone with the Wind'
life
Sport
David Silva strokes home his and City's second goal
football
Arts and Entertainment
a clockwork orange, stanley kubrick
film
Extras
The Tesco Hudl2: An exceptional Android tablet that's powerful, well-built and outstanding value
indybest

News
Sarah Silverman (middle) with sister Reform Rabbi Susan Silverman (right) and sister actress Laura Silverman (left) at Jerusalem's Western Wall for feminist Hanuka candle-lighting ceremony
peopleControversial comedian stages pro-equality Hanukkah lighting during a protest at Jerusalem's Wailing Wall
Sport
After another poor series in Sri Lanka, Alastair Cook claimed all players go through a lean period
cricket
Arts and Entertainment
The Bach Choir has been crowned the inaugural winner of Sky Arts’ show The Great Culture Quiz
arts + ents140-year-old choir declared winner of Sky Arts' 'The Great Culture Quiz'
Life and Style
food + drinkAuthor DBC Pierre presents his guide to the morning after
Life and Style
food + drink
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Carlton Senior Appointments: Private Banking Manager - Intl Bank - Los Angeles

$200 - $350 per annum: Carlton Senior Appointments: Managing Producer – Office...

Carlton Senior Appointments: San Fran - Investment Advisor – Ind Advisory Firm

$125 - $225 per annum: Carlton Senior Appointments: San Fran - Investment Advi...

Sheridan Maine: Commercial Finance Manager

Up to £70,000 per annum + benefits: Sheridan Maine: Are you a qualified accoun...

Sheridan Maine: Regulatory Reporting Accountant

Up to £65,000 per annum + benefits: Sheridan Maine: Are you a qualified accoun...

Day In a Page

Homeless Veterans appeal: 'You look for someone who's an inspiration and try to be like them'

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Could cannabis oil reverse the effects of cancer?

Could cannabis oil reverse effects of cancer?

As a film following six patients receiving the controversial treatment is released, Kate Hilpern uncovers a very slippery issue
The Interview movie review: You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here

The Interview movie review

You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here
Serial mania has propelled podcasts into the cultural mainstream

How podcasts became mainstream

People have consumed gripping armchair investigation Serial with a relish typically reserved for box-set binges
Jesus Christ has become an unlikely pin-up for hipster marketing companies

Jesus Christ has become an unlikely pin-up

Kevin Lee Light, aka "Jesus", is the newest client of creative agency Mother while rival agency Anomaly has launched Sexy Jesus, depicting the Messiah in a series of Athena-style poses
Rosetta space mission voted most important scientific breakthrough of 2014

A memorable year for science – if not for mice

The most important scientific breakthroughs of 2014
Christmas cocktails to make you merry: From eggnog to Brown Betty and Rum Bumpo

Christmas cocktails to make you merry

Mulled wine is an essential seasonal treat. But now drinkers are rediscovering other traditional festive tipples. Angela Clutton raises a glass to Christmas cocktails
5 best activity trackers

Fitness technology: 5 best activity trackers

Up the ante in your regimen and change the habits of a lifetime with this wearable tech
Paul Scholes column: It's a little-known fact, but I have played one of the seven dwarves

Paul Scholes column

It's a little-known fact, but I have played one of the seven dwarves
Fifa's travelling circus once again steals limelight from real stars

Fifa's travelling circus once again steals limelight from real stars

Club World Cup kicked into the long grass by the continued farce surrounding Blatter, Garcia, Russia and Qatar
Frank Warren column: 2014 – boxing is back and winning new fans

Frank Warren: Boxing is back and winning new fans

2014 proves it's now one of sport's biggest hitters again
Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

Jeb Bush vs Hillary Clinton

Karen Tumulty explores the power dynamics of the two first families
Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

Stockholm is rivalling Silicon Valley

The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

Crucified Santa: Urban myth refuses to die

The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture
Jennifer Saunders and Kate Moss join David Walliams on set for TV adaptation of The Boy in the Dress

The Boy in the Dress: On set with the stars

Walliams' story about a boy who goes to school in a dress will be shown this Christmas